CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Study in Hematological Malignancies	14/11/2014	Registered
Jusvinza in Severe Patients with Acquired Community Pneumonia	14/10/2022	Registered
Safety and immunogenicity of the CIGB 2020.	14/07/2020	Registered outdated
CIGB-258 at COVID-19	14/05/2020	Registered outdated
ESPERANZA study	14/04/2020	Registered outdated
COURAGE-2 Study	14/03/2019	Registered outdated
CIGB 2020 in contacts and SARS-CoV-2 infection suspects	13/04/2020	Registered outdated
BACONAO Study	12/11/2021	Registered outdated
Nasalferon in COVID-19	12/11/2021	Registered
DALIA Study	11/08/2020	Registered outdated
CIGB2020- ARI elderly contacts	11/03/2021	Registered outdated
Expanded Clinical Use of Nasalferon in COVID-19	10/11/2021	Registered outdated
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized.	10/11/2014	Registered
CIGB-Mambisa/Abdala in convalescents	09/07/2021	Registered outdated
THERESA-5 Study	08/04/2015	Registered
AMIGOS-2 study	07/08/2018	Registered outdated
CERVICONC-II-300 study	07/08/2018	Registered outdated
Nasal recombinant human interferon alfa-2b in ARI	06/12/2022	Registered
Transfer factor in Chronic Kidney Disease	06/08/2020	Registered outdated
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock	06/07/2023	Registered